Respiratory Viral Infection: Clinical Trials

45 trials for Respiratory Viral Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 6 recruiting, 6 unknown, 4 terminated. 11 Not applicable, 9 Phase 3, 6 Phase 2, 3 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 5, Unknown 3, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 39Completed 6, Recruiting 1, Terminated 1, Withdrawn 1
Phase 26Completed 3, Recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 2, Recruiting 1
Phase 43Active not recruiting 1, Completed 1, Terminated 1

Follow Respiratory Viral Infection: new trials by email Literature Review of Respiratory Viral Infection trials Research Report on Respiratory Viral Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses
AP1189, 100 mg, Placebo - Respiratory Viral Infection
Phase 2RecruitingSynAct Pharma Aps962026-05-012026-07-28
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
JKN2301 Dry Suspension, Oseltamivir Placebo, Oseltamivir - Respiratory Viral Infection
Phase 3RecruitingJoincare Pharmaceutical Group Industry Co., Ltd1772025-11-072026-01-21
Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza
ZX-7101A for oral suspension, Oseltamivir phosphate for oral suspension - Respiratory Viral Infection
Phase 3CompletedNanjing Zenshine Pharmaceuticals1692025-10-132026-04-16
Reducing Respiratory Virus Transmission in Bangladeshi Classrooms
Box Fan, UV Germicidal Irradiation Lamp Unit, Combined: Box Fan and UV Germicidal Irradiation Lamp Units - SARS-CoV2 Infection, Influenza Viral Infections
Not applicableWithdrawnStanford University2025-10-012026-08-24
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
ZX-7101A dry suspension, ZX-7101A tablet - Respiratory Viral Infection
Phase 1CompletedNanjing Zenshine Pharmaceuticals402025-02-202025-05-11
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
ZX-7101A, Placebo for ZX-7101A tablet, Oseltamivir phosphate dry suspension - Respiratory Viral Infection
Phase 3TerminatedNanjing Zenshine Pharmaceuticals982024-10-312025-08-13
Dime La VerDAD: Verify, Debunk, and Disseminate
Science Communication Curriculum Cohort 1, Science communication curriculum Cohort 2, Science communication curriculum Cohort 3 - Influenza, COVID-19
Not applicableRecruitingUniversity of Chicago14002024-07-022026-08-26
Assessment of the Type I IFN Response in the Nasal Cavity During Respiratory Viral Infections in a Geriatric Department
Evaluate IFN-I score for detecting respiratory viral infection vs first-line tests (flu, SARS-CoV-2, RSV) in geriatric patients or REFIPA participants with PCR-confirmed infection. - Respiratory Viral Infection
RecruitingHospices Civils de Lyon11402024-01-042026-05-22
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza
ZX-7101A, Placebo - Respiratory Viral Infection
Phase 3CompletedNanjing Zenshine Pharmaceuticals3612023-11-302025-02-19
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Vapendavir, Placebo - COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection
Phase 2CompletedAltesa Biosciences, Inc.522023-11-202025-09-30
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Cystic Fibrosis in Children, Respiratory Bacterial Infection
CompletedUniversity Hospital, Antwerp222023-11-012026-08-12
Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics
SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1 - Respiratory Viral Infection
Not applicableUnknownAusDiagnostics Pty Ltd.10002023-07-012023-07-14
Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Respiratory Syncytial Virus (RSV), Respiratory Viral Infection
Active not recruitingInstitute for Clinical Effectiveness, Japan30672023-07-012025-07-20
Macrophage Regulation of Ozone-Induced Lung Inflammation
Ozone - Respiratory Viral Infection
Phase 1RecruitingRobert Tighe, MD1002023-05-182026-05-15
The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
Respiratory Viral Infection
CompletedUniversity of Wisconsin, Madison1202023-05-052023-10-27
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Hematopoietic Cell Transplant, Solid Organ Transplant
RecruitingArkansas Children's Hospital Research Institute20002022-12-132025-10-02
Xylitol Based Nasal Spray for COVID-19 Treatment
Nasal Spray - Respiratory Viral Infection
Not applicableUnknownXlear, Inc802022-11-282022-11-23
Respiferon Project
Evaluate the performance of IFN I/III - Respiratory Viral Infection
UnknownHospices Civils de Lyon10002022-11-112023-08-30
Zinc and Green Tea Extract for Community Respiratory Viral Infections
zinc-green tea extract-ascorbic acid, Placebo - Respiratory Viral Infection
Phase 2TerminatedUniversity of Missouri-Columbia172022-09-212025-03-07
Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers
XC8 - Influenza, Respiratory Viral Infection
Not applicableCompletedValenta Pharm JSC242022-08-222023-10-10

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

COVID-19 (14)  ·  Influenza, Human (12)  ·  Common Cold (4)  ·  Respiratory Tract Infections (4)  ·  Virus Diseases (4)  ·  Severe Acute Respiratory Syndrome (3)  ·  Acute Disease (2)  ·  Infections (2)  ·  Pneumonia (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Bacterial Infections (1)  ·  Communicable Diseases (1)  ·  Coronavirus Infections (1)  ·  Cystic Fibrosis (1)

Broader conditions

Infections (26)  ·  Respiratory Tract Diseases (26)  ·  RNA Virus Infections (22)  ·  Respiratory Tract Infections (22)  ·  Virus Diseases (21)  ·  Lung Diseases (16)  ·  Coronaviridae Infections (14)  ·  Nidovirales Infections (14)  ·  Pneumonia, Viral (14)  ·  Coronavirus Infections (13)  ·  Pneumonia (13)  ·  Orthomyxoviridae Infections (12)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Pathologic Processes (5)  ·  Disease Attributes (4)

Interventions

Oseltamivir (2)  ·  Tobacco Use Cessation Devices (2)  ·  Broncho-Vaxom (1)  ·  Cold Temperature (1)  ·  Diagnosis (1)  ·  Diagnostic Imaging (1)  ·  Influenza Vaccines (1)  ·  Interferon-alpha (1)  ·  N-(3-(1-(2-nitrophenyl)-1H-pyrrol-2-yl)allylidenamino)guanidine (1)  ·  N95 Respirators (1)  ·  Ozone (1)  ·  Respiratory Rate (1)  ·  Restraint, Physical (1)  ·  Standard of Care (1)  ·  Suspensions (1)

Sponsors

Nanjing Zenshine Pharmaceuticals (4)  ·  Hospices Civils de Lyon (3)  ·  Nearmedic Plus LLC (2)  ·  Temple University (2)  ·  University of Washington (2)  ·  Valenta Pharm JSC (2)  ·  Altesa Biosciences, Inc. (1)  ·  Arkansas Children's Hospital Research Institute (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AusDiagnostics Pty Ltd. (1)  ·  CCTU- Cancer Theme (1)  ·  Duke University (1)  ·  Evidation Health (1)  ·  Imperial College London (1)  ·  Institute for Clinical Effectiveness, Japan (1)

Countries

United States (15)  ·  China (5)  ·  Russia (5)  ·  France (4)  ·  United Kingdom (4)  ·  Australia (2)  ·  Austria (1)  ·  Belgium (1)  ·  Bosnia and Herzegovina (1)  ·  Greece (1)  ·  Japan (1)  ·  Montenegro (1)  ·  New Zealand (1)  ·  Serbia (1)  ·  The Gambia (1)

Top investigators

Helen Y Chu, MD, MPH (2)  ·  Ahsan W Rathore, MBBS (1)  ·  Barry Lutz, PhD (1)  ·  Carol L Wagner, MD (1)  ·  Christopher Chiu, PhD (1)  ·  Christos Lionis (1)  ·  Elena Tikhonova, Dr. habilitated, Professor (1)  ·  Ernesto Ramirez, PhD (1)  ·  Gabriela Maron, MD (1)  ·  Hanmin Liu, MD (1)  ·  Heather M Murphy, PhD (1)  ·  Heather Murphy, PhD (1)  ·  Iulia Niculescu, MD (1)  ·  Janielle R Nordell, MD (1)  ·  Jessie L Juusola, PhD (1)

Results publications

PMID 11027360, PMID 12165190, PMID 24392148, PMID 25645191, PMID 27040626, PMID 28250669, PMID 28934952, PMID 30634637, PMID 30713281, PMID 31133031, PMID 31390800, PMID 32306836, PMID 32327758, PMID 32435816, PMID 32770170, PMID 32826428, PMID 32931328, PMID 33006303, PMID 33173650, PMID 33199918, PMID 33228787, PMID 33390932, PMID 33937883, PMID 34473343, PMID 34558405, PMID 34797868, PMID 34863618, PMID 35101893, PMID 35435222, PMID 35749582, PMID 36276877, PMID 36863739, PMID 36951890, PMID 37470740, PMID 38471990, PMID 38481147, PMID 38626982, PMID 40874769, PMID 42147197, PMID 7486925, PMID 9872255

NIH funding

R01AI153376 (1), R01AI159684 (1), R01ES034350 (1), R01MD018730 (1)